SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-004465
Filing Date
2019-05-08
Accepted
2019-05-08 16:15:18
Documents
3
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 35497
2 EX-99.1 ex-99d1.htm EX-99.1 151382
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 17887
  Complete submission text file 0001558370-19-004465.txt   212774
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 19806774
SIC: 2834 Pharmaceutical Preparations